Mitochondrial targeting functional peptides as potential devices for the mitochondrial delivery of a DF-MITO-Porter

Mitochondrion

Volumn 13, Issue 6, 2013, Pages 610-614

  Kawamura, Eriko ^a   Yamada, Yuma ^a   Harashima, Hideyoshi ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

MITO Porter; Mitochondria; Mitochondrial drug delivery; Mitochondrial targeting peptide; Nanoparticles; S2 peptide

Indexed keywords

CELL PENETRATING PEPTIDE; LIGAND; LIPOSOME; NANOCARRIER;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL ISOLATION; CELL MEMBRANE PERMEABILITY; CELL TRANSPORT; CONTROLLED STUDY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; INTERMETHOD COMPARISON; INTRACELLULAR TRANSPORT; LIVER HOMOGENATE; MALE; MITOCHONDRIAL TARGETING SIGNAL; MITOCHONDRION; NONHUMAN; PRIORITY JOURNAL; PROTEIN TRANSPORT; RAT;

MITO-PORTER; MITOCHONDRIA; MITOCHONDRIAL DRUG DELIVERY; MITOCHONDRIAL TARGETING PEPTIDE; NANOPARTICLES; S2 PEPTIDE;

ANIMALS; DRUG CARRIERS; HELA CELLS; HUMANS; MITOCHONDRIA; PEPTIDES; RATS;

EID: 84884563383     PISSN: 15677249     EISSN: 18728278     Source Type: Journal    
DOI: 10.1016/j.mito.2013.08.010     Document Type: Article

References (31)

1. Adhya S., Mahato B., Jash S., Koley S., Dhar G., Chowdhury T. Mitochondrial gene therapy: the tortuous path from bench to bedside. Mitochondrion 2011, 11:839-844.
2. Akita H., Kudo A., Minoura A., Yamaguti M., Khalil I.A., Moriguchi R., Masuda T., Danev R., Nagayama K., Kogure K., Harashima H. Multi-layered nanoparticles for penetrating the endosome and nuclear membrane via a step-wise membrane fusion process. Biomaterials 2009, 30:2940-2949.
3. Akita H., Kogure K., Moriguchi R., Nakamura Y., Higashi T., Nakamura T., Serada S., Fujimoto M., Naka T., Futaki S., Harashima H. Reprint of: Nanoparticles for ex vivo siRNA delivery to dendritic cells for cancer vaccines: programmed endosomal escape and dissociation. J. Control. Release 2011, 149:58-64.
4. Chan D.C. Mitochondria: dynamic organelles in disease, aging, and development. Cell 2006, 125:1241-1252.
5. D'Souza G.G.M., Rammohan R., Cheng S.M., Torchilin V.P., Weissig V. DQAsome-mediated delivery of plasmid DNA toward mitochondria in living cells. J. Control. Release 2003, 92:189-197.
6. El-Sayed A., Khalil I.A., Kogure K., Futaki S., Harashima H. Octaarginine- and octalysine-modified nanoparticles have different modes of endosomal escape. J. Biol. Chem. 2008, 283:23450-23461.
7. Fink M.P., Macias C.A., Xiao J., Tyurina Y.Y., Jiang J., Belikova N., Delude R.L., Greenberger J.S., Kagan V.E., Wipf P. Hemigramicidin-TEMPO conjugates: novel mitochondria-targeted anti-oxidants. Biochem. Pharmacol. 2007, 74:801-809.
8. Flierl A., Jackson C., Cottrell B., Murdock D., Seibel P., Wallace D.C. Targeted delivery of DNA to the mitochondrial compartment via import sequence-conjugated peptide nucleic acid. Mol. Ther. 2003, 7:550-557.
9. Futaki S., Ohashi W., Suzuki T., Niwa M., Tanaka S., Ueda K., Harashima H., Sugiura Y. Stearylated arginine-rich peptides: a new class of transfection systems. Bioconjug. Chem. 2001, 12:1005-1011.
10. Futaki S., Masui Y., Nakase I., Sugiura Y., Nakamura T., Kogure K., Harashima H. Unique features of a pH-sensitive fusogenic peptide that improves the transfection efficiency of cationic liposomes. J. Gene Med. 2005, 7:1450-1458.
11. Horton K.L., Stewart K.M., Fonseca S.B., Guo Q., Kelley S.O. Mitochondria-penetrating peptides. Chem. Biol. 2008, 15:375-382.
12. Horton K.L., Pereira M.P., Stewart K.M., Fonseca S.B., Kelley S.O. Tuning the activity of mitochondria-penetrating peptides for delivery or disruption. ChemBioChem 2012, 13:476-485.
13. Hossen M.N., Kajimoto K., Akita H., Hyodo M., Ishitsuka T., Harashima H. Ligand-based targeted delivery of a peptide modified nanocarrier to endothelial cells in adipose tissue. J. Control. Release 2010, 147:261-268.
14. Kawamura E., Yamada Y., Yasuzaki Y., Hyodo M., Harashima H. Intracellular observation of nanocarriers modified with a mitochondrial targeting signal peptide. J. Biosci. Bioeng. 2013, 10.1016/j.jbiosc.2013.05.001.
15. Khalil I.A., Kogure K., Futaki S., Harashima H. High density of octaarginine stimulates macropinocytosis leading to efficient intracellular trafficking for gene expression. J. Biol. Chem. 2006, 281:3544-3551.
16. Koczor C.A., Snyder J.W., Shokolenko I.N., Dobson A.W., Wilson G.L., Ledoux S.P. Targeting Repair proteins to the mitochondria of mammalian cells through stable transfection, transient transfection, viral transduction, and TAT-mediated protein transduction. Methods Mol. Biol. 2009, 554:233-249.
17. Kolonin M.G., Saha P.K., Chan L., Pasqualini R., Arap W. Reversal of obesity by targeted ablation of adipose tissue. Nat. Med. 2004, 10:625-632.
18. Mahata B., Mukherjee S., Mishra S., Bandyopadhyay A., Adhya S. Functional delivery of a cytosolic tRNA into mutant mitochondria of human cells. Science 2006, 314:471-474.
19. Schapira A.H.V. Mitochondrial disease. Lancet 2012, 379:1825-1834.
20. Szeto H.H., Schiller P.W. Novel therapies targeting inner mitochondrial membrane-from discovery to clinical development. Pharm. Res. 2011, 28:2669-2679.
21. Taylor R.W., Turnbull D.M. Mitochondrial DNA mutations in human disease. Nat. Rev. Genet. 2005, 6:389-402.
22. Wipf P., Xiao J., Jiang J., Belikova N.A., Tyurin V.A., Fink M.P., Kagan V.E. Mitochondrial targeting of selective electron scavengers: synthesis and biological analysis of hemigramicidin-TEMPO conjugates. J. Am. Chem. Soc. 2005, 127:12460-12461.
23. Yamada Y., Akita H., Kamiya H., Kogure K., Yamamoto T., Shinohara Y., Yamashita K., Kobayashi H., Kikuchi H., Harashima H. MITO-Porter: a liposome-based carrier system for delivery of macromolecules into mitochondria via membrane fusion. Biochim. Biophys. Acta 2008, 1778:423-432.
24. Yamada Y., Harashima H. Mitochondrial drug delivery systems for macromolecule and their therapeutic application to mitochondrial diseases. Adv. Drug Deliv. Rev. 2008, 60:1439-1462.
25. Yamada Y., Furukawa R., Yasuzaki Y., Harashima H. Dual function MITO-Porter, a nano carrier integrating both efficient cytoplasmic delivery and mitochondrial macromolecule delivery. Mol. Ther. 2011, 19:1449-1456.
26. Yamada Y., Harashima H. Delivery of bioactive molecules to the mitochondrial genome using a membrane-fusing, liposome-based carrier, DF-MITO-Porter. Biomaterials 2012, 33:1589-1595.
27. Yamada Y., Kawamura E., Harashima H. Mitochondrial-targeted DNA delivery using a DF-MITO-Porter, an innovative nano carrier with cytoplasmic and mitochondrial fusogenic envelopes. J. Nanopart. Res. 2012, 14:1013.
28. Yamada Y., Harashima H. Enhancement in selective mitochondrial association by direct modification of a mitochondrial targeting signal peptide on a liposomal based nanocarrier. Mitochondrion 2013, 10.1016/j.mito.2012.09.001.
29. Yasuzaki Y., Yamada Y., Harashima H. Mitochondrial matrix delivery using MITO-Porter, a liposome-based carrier that specifies fusion with mitochondrial membranes. Biochem. Biophys. Res. Commun. 2010, 397:181-186.
30. Zhang E., Zhang C., Su Y., Cheng T., Shi C. Newly developed strategies for multifunctional mitochondria-targeted agents in cancer therapy. Drug Discov. Today 2011, 16:140-146.
31. Zhao K., Zhao G.M., Wu D., Soong Y., Birk A.V., Schiller P.W., Szeto H.H. Cell-permeable peptide antioxidants targeted to inner mitochondrial membrane inhibit mitochondrial swelling, oxidative cell death, and reperfusion injury. J. Biol. Chem. 2004, 279:34682-34690.